The effect of simvastatin on chemotactic capability of SDF-1α and the promotion of bone regeneration

Biomaterials

Volumn 35, Issue 15, 2014, Pages 4489-4498

  Liu, Yun Song ^a   Ou, Meng En ^a   Liu, Hao ^a   Gu, Ming ^a   Lv, Long Wei ^a   Fan, Cong ^a   Chen, Tong ^a   Zhao, Xiang Hui ^a   Jin, Chan Yuan ^a   Zhang, Xiao ^a   Ding, Yun ^a   Zhou, Yong Sheng ^a  

^a PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

Author keywords

Bone healing; Cell homing; Simvastatin; Stromal cell derived factor 1

Indexed keywords

BONE; CELL CULTURE; CELL PROLIFERATION; COMPUTERIZED TOMOGRAPHY; COPOLYMERS; FLOWCHARTING; MAMMALS; PHOSPHATASES; TISSUE;

ALKALINE PHOSPHATASE ACTIVITY; BONE HEALING; BONE TISSUE ENGINEERING; CO-OPERATIVE EFFECTS; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; SIMVASTATIN; STROMAL CELL-DERIVED FACTOR 1;

SCAFFOLDS (BIOLOGY);

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; POLYGLACTIN; SIMVASTATIN; STROMAL CELL DERIVED FACTOR 1ALPHA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; BONE REGENERATION; CALVARIA; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVITY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE ENGINEERING;

MUS;

BONE HEALING; CELL HOMING; SIMVASTATIN; STROMAL CELL-DERIVED FACTOR 1;

ALKALINE PHOSPHATASE; ANIMALS; BONE MARROW CELLS; BONE REGENERATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CXCL12; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MESENCHYMAL STROMAL CELLS; MICE; SIMVASTATIN; SKULL; TISSUE ENGINEERING;

EID: 84896052134     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.02.025     Document Type: Article

References (66)

1. Liu Y., Zhou Y., Feng H., Ma G.E., Ni Y. Injectable tissue-engineered bone composed of human adipose-derived stromal cells and platelet-rich plasma. Biomaterials 2008, 29:3338-3345.
2. Steinhardt Y., Aslan H., Regev E., Zilberman Y., Kallai I., Gazit D., et al. Maxillofacial-derived stem cells regenerate critical mandibular bone defect. Tissue Eng Part A 2008, 14:1763-1773.
3. Im J.Y., Min W.K., You C., Kim H.O., Jin H.K., Bae J.S. Bone regeneration of mouse critical-sized calvarial defects with human mesenchymal stem cells in scaffold. Lab Anim Res 2013, 29:196-203.
4. Zhou Y.S., Liu Y.S., Tan J.G. Is 1, 25-dihydroxyvitamin D3 an ideal substitute for dexamethasone for inducing osteogenic differentiation of human adipose tissue-derived stromal cells invitro?. Chin Med J Engl 2006, 119:1278-1286.
5. Liu Y., Zhao Y., Zhang X., Chen T., Zhao X., Ma G.E., et al. Flow cytometric cell sorting and invitro pre-osteoinduction are not requirements for invivo bone formation by human adipose-derived stromal cells. PLoS One 2013, 8:e56002.
6. Castano-Izquierdo H., Alvarez-Barreto J., van den Dolder J., Jansen J.A., Mikos A.G., Sikavitsas V.I. Pre-culture period of mesenchymal stem cells in osteogenic media influences their invivo bone forming potential. JBiomed Mater Res A 2007, 82:129-138.
7. Stocum D.L., Zupanc G.K. Stretching the limits: stem cells in regeneration science. Dev Dyn 2008, 237:3648-3671.
8. Bonab M.M., Alimoghaddam K., Talebian F., Ghaffari S.H., Ghavamzadeh A., Nikbin B. Aging of mesenchymal stem cell invitro. BMC Cell Biol 2006, 7:14.
9. Crisostomo P.R., Wang M., Wairiuko G.M., Morrell E.D., Terrell A.M., Seshadri P., et al. High passage number of stem cells adversely affects stem cell activation and myocardial protection. Shock 2006, 26:575-580.
10. Kim K., Lee C.H., Kim B.K., Mao J.J. Anatomically shaped tooth and periodontal regeneration by cell homing. JDent Res 2010, 89:842-847.
11. Yu L., Cecil J., Peng S.B., Schrementi J., Kovacevic S., Paul D., et al. Identification and expression of novel isoforms of human stromal cell-derived factor 1. Gene 2006, 374:174-179.
12. Shirozu M., Nakano T., Inazawa J., Tashiro K., Tada H., Shinohara T., et al. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 1995, 28:495-500.
13. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12:121-127.
14. Ma Q., Jones D., Borghesani P.R., Segal R.A., Nagasawa T., Kishimoto T., et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci U S A 1998, 95:9448-9453.
15. Nagasawa T., Hirota S., Tachibana K., Takakura N., Nishikawa S., Kitamura Y., et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996, 382:635-638.
16. Zou Y.R., Kottmann A.H., Kuroda M., Taniuchi I., Littman D.R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998, 393:595-599.
17. Aiuti A., Tavian M., Cipponi A., Ficara F., Zappone E., Hoxie J., et al. Expression of CXCR4, the receptor for stromal cell-derived factor-1 on fetal and adult human lympho-hematopoietic progenitors. Eur J Immunol 1999, 29:1823-1831.
18. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998, 392:565-568.
19. Yu X., Huang Y., Collin-Osdoby P., Osdoby P. Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration. JBone Miner Res 2003, 18:1404-1418.
20. Ji J.F., He B.P., Dheen S.T., Tay S.S. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 2004, 22:415-427.
21. Zhao T., Zhang D., Millard R.W., Ashraf M., Wang Y. Stem cell homing and angiomyogenesis in transplanted hearts are enhanced by combined intramyocardial SDF-1alpha delivery and endogenous cytokine signaling. Am J Physiol Heart Circ Physiol 2009, 296:H976-H986.
22. Ratajczak M.Z., Majka M., Kucia M., Drukala J., Pietrzkowski Z., Peiper S., et al. Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles. Stem Cells 2003, 21:363-371.
23. Hatch H.M., Zheng D., Jorgensen M.L., Petersen B.E. SDF-1alpha/CXCR4: a mechanism for hepatic oval cell activation and bone marrow stem cell recruitment to the injured liver of rats. Cloning Stem Cells 2002, 4:339-351.
24. Togel F., Isaac J., Hu Z., Weiss K., Westenfelder C. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int 2005, 67:1772-1784.
25. Ceradini D.J., Kulkarni A.R., Callaghan M.J., Tepper O.M., Bastidas N., Kleinman M.E., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004, 10:858-864.
26. Kitaori T., Ito H., Schwarz E.M., Tsutsumi R., Yoshitomi H., Oishi S., et al. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum 2009, 60:813-823.
27. Otsuru S., Tamai K., Yamazaki T., Yoshikawa H., Kaneda Y. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway. Stem Cells 2008, 26:223-234.
28. Hosogane N., Huang Z., Rawlins B.A., Liu X., Boachie-Adjei O., Boskey A.L., et al. Stromal derived factor-1 regulates bone morphogenetic protein 2-induced osteogenic differentiation of primary mesenchymal stem cells. Int J Biochem Cell Biol 2010, 42:1132-1141.
29. Cei S., Kandler B., Fugl A., Gabriele M., Hollinger J.O., Watzek G., et al. Bone marrow stromal cells of young and adult rats respond similarly to platelet-released supernatant and bone morphogenetic protein-6 invitro. JPeriodontol 2006, 77:699-706.
30. Fujii M., Takeda K., Imamura T., Aoki H., Sampath T.K., Enomoto S., et al. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol Biol Cell 1999, 10:3801-3813.
31. Gu K., Zhang L., Jin T., Rutherford R.B. Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7. Cells Tissues Organs 2004, 176:28-40.
32. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. JCell Biol 1994, 127:1755-1766.
33. Yeh L.C., Tsai A.D., Lee J.C. Osteogenic protein-1 (OP-1, BMP-7) induces osteoblastic cell differentiation of the pluripotent mesenchymal cell line C2C12. JCell Biochem 2002, 87:292-304.
34. Zachos T.A., Shields K.M., Bertone A.L. Gene-mediated osteogenic differentiation of stem cells by bone morphogenetic proteins-2 or -6. JOrthop Res 2006, 24:1279-1291.
35. Zhu W., Kim J., Cheng C., Rawlins B.A., Boachie-Adjei O., Crystal R.G., et al. Noggin regulation of bone morphogenetic protein (BMP) 2/7 heterodimer activity invitro. Bone 2006, 39:61-71.
36. Chen D., Zhao M., Mundy G.R. Bone morphogenetic proteins. Growth Factors 2004, 22:233-241.
37. Zhang X., Guo J., Zhou Y., Wu G. The roles of bone morphogenetic proteins and their signaling in the osteogenesis of adipose-derived stem cells. Tissue Eng Part B Rev 2013, [Ahead of print]. 10.1089/ten.teb.2013.0204.
38. Wang C.K., Ho M.L., Wang G.J., Chang J.K., Chen C.H., Fu Y.C., et al. Controlled-release of rhBMP-2 carriers in the regeneration of osteonecrotic bone. Biomaterials 2009, 30:4178-4186.
39. Benglis D., Wang M.Y., Levi A.D. Acomprehensive review of the safety profile of bone morphogenetic protein in spine surgery. Neurosurgery 2008, 62:ONS423-ONS431.
40. Chen N.F., Smith Z.A., Stiner E., Armin S., Sheikh H., Khoo L.T. Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion. JNeurosurg Spine 2010, 12:40-46.
41. Zhou Y., Ni Y., Liu Y., Zeng B., Xu Y., Ge W. The role of simvastatin in the osteogenesis of injectable tissue-engineered bone based on human adipose-derived stromal cells and platelet-rich plasma. Biomaterials 2010, 31:5325-5335.
42. Stein D., Lee Y., Schmid M.J., Killpack B., Genrich M.A., Narayana N., et al. Local simvastatin effects on mandibular bone growth and inflammation. JPeriodontol 2005, 76:1861-1870.
43. Nyan M., Sato D., Oda M., Machida T., Kobayashi H., Nakamura T., et al. Bone formation with the combination of simvastatin and calcium sulfate in critical-sized rat calvarial defect. JPharmacol Sci 2007, 104:384-386.
44. Wu Z., Liu C., Zang G., Sun H. The effect of simvastatin on remodelling of the alveolar bone following tooth extraction. Int J Oral Maxillofac Surg 2008, 37:170-176.
45. Ozec I., Kilic E., Gumus C., Goze F. Effect of local simvastatin application on mandibular defects. JCraniofac Surg 2007, 18:546-550.
46. Cui Y., Han X., Wang J., Song Q., Tan J., Fu X., et al. Calvarial defect healing by recruitment of autogenous osteogenic stem cells using locally applied simvastatin. Biomaterials 2013, 34:9373-9380.
47. Han X., Yang N., Cui Y., Xu Y., Dang G., Song C. Simvastatin mobilizes bone marrow stromal cells migrating to injured areas and promotes functional recovery after spinal cord injury in the rat. Neurosci Lett 2012, 521:136-141.
48. Nadri S., Soleimani M., Hosseni R.H., Massumi M., Atashi A., Izadpanah R. An efficient method for isolation of murine bone marrow mesenchymal stem cells. Int J Dev Biol 2007, 51:723-729.
49. Thevenot P.T., Nair A.M., Shen J., Lotfi P., Ko C.-Y., Tang L. The effect of incorporation of SDF-1α into PLGA scaffolds on stem cell recruitment and the inflammatory response. Biomaterials 2010, 31:3997-4008.
50. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
51. Gang E.J., Bosnakovski D., Figueiredo C.A., Visser J.W., Perlingeiro R.C. SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 2007, 109:1743-1751.
52. Chemokine/chemokine receptor nomenclature. Cytokine 2003, 21:48-49.
53. Holland J.D., Kochetkova M., Akekawatchai C., Dottore M., Lopez A., McColl S.R. Differential functional activation of chemokine receptor CXCR4 is mediated by G proteins in breast cancer cells. Cancer Res 2006, 66:4117-4124.
54. Wong D., Korz W. Translating an antagonist of chemokine receptor CXCR4: from bench to bedside. Clin Cancer Res 2008, 14:7975-7980.
55. Ganju R.K., Brubaker S.A., Meyer J., Dutt P., Yang Y., Qin S., et al. The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. JBiol Chem 1998, 273:23169-23175.
56. Zhao M., Discipio R.G., Wimmer A.G., Schraufstatter I.U. Regulation of CXCR4-mediated nuclear translocation of extracellular signal-related kinases 1 and 2. Mol Pharmacol 2006, 69:66-75.
57. Busillo J.M., Benovic J.L. Regulation of CXCR4 signaling. Biochim Biophys Acta 2007, 1768:952-963.
58. Chinni S.R., Sivalogan S., Dong Z., Filho J.C., Deng X., Bonfil R.D., et al. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12. Prostate 2006, 66:32-48.
59. Qi Y., Zhao T., Yan W., Xu K., Shi Z., Wang J. Mesenchymal stem cell sheet transplantation combined with locally released simvastatin enhances bone formation in a rat tibia osteotomy model. Cytotherapy 2013, 15:44-56.
60. Jain R.A. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000, 21:2475-2490.
61. Mundy G., Garrett R., Harris S., Chan J., Chen D., Rossini G., et al. Stimulation of bone formation invitro and in rodents by statins. Science 1999, 286:1946-1949.
62. Choi K.Y., Kim H.J., Lee M.H., Kwon T.G., Nah H.D., Furuichi T., et al. Runx2 regulates FGF2-induced Bmp2 expression during cranial bone development. Dev Dyn 2005, 233:115-121.
63. Kanczler J.M., Oreffo R.O. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 2008, 15:100-114.
64. Stellos K., Langer H., Daub K., Schoenberger T., Gauss A., Geisler T., et al. Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells. Circulation 2008, 117:206-215.
65. Bouletreau P.J., Warren S.M., Spector J.A., Peled Z.M., Gerrets R.P., Greenwald J.A., et al. Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing. Plast Reconstr Surg 2002, 109:2384-2397.
66. Deckers M.M., van Bezooijen R.L., van der Horst G., Hoogendam J., van Der Bent C., Papapoulos S.E., et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 2002, 143:1545-1553.